Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma

Megan L. Ludwig, Andrew C. Birkeland, Rebecca Hoesli, Paul Swiecicki, Matthew E. Spector, J. Chad Brenner

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Laryngeal squamous cell carcinoma (LSCC) remains a highly morbid and fatal disease. Historically, it has been a model example for organ preservation and treatment stratification paradigms. Unfortunately, survival for LSCC has stagnated over the past few decades. As the era of next-generation sequencing and personalized treatment for cancer approaches, LSCC may be an ideal disease for consideration of further treatment stratification and personalization. Here, we will discuss the important history of LSCC as a model system for organ preservation, unique and potentially targetable genetic signatures of LSCC, and methods for bringing stratified, personalized treatment strategies to the 21st century.

Original languageEnglish (US)
Pages (from-to)87-100
Number of pages14
JournalCancer Biology and Medicine
Volume13
Issue number1
DOIs
StatePublished - Mar 1 2016
Externally publishedYes

Fingerprint

Squamous Cell Carcinoma
Organ Preservation
Therapeutics
Laryngeal Neoplasms
History

Keywords

  • Genetics
  • Head and neck cancer
  • Laryngeal squamous cell carcinoma
  • Personalized medicine
  • Targeted therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Changing the paradigm : the potential for targeted therapy in laryngeal squamous cell carcinoma. / Ludwig, Megan L.; Birkeland, Andrew C.; Hoesli, Rebecca; Swiecicki, Paul; Spector, Matthew E.; Chad Brenner, J.

In: Cancer Biology and Medicine, Vol. 13, No. 1, 01.03.2016, p. 87-100.

Research output: Contribution to journalReview article

Ludwig, Megan L. ; Birkeland, Andrew C. ; Hoesli, Rebecca ; Swiecicki, Paul ; Spector, Matthew E. ; Chad Brenner, J. / Changing the paradigm : the potential for targeted therapy in laryngeal squamous cell carcinoma. In: Cancer Biology and Medicine. 2016 ; Vol. 13, No. 1. pp. 87-100.
@article{c89b0a0ee0d447229990c6a97927e66d,
title = "Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma",
abstract = "Laryngeal squamous cell carcinoma (LSCC) remains a highly morbid and fatal disease. Historically, it has been a model example for organ preservation and treatment stratification paradigms. Unfortunately, survival for LSCC has stagnated over the past few decades. As the era of next-generation sequencing and personalized treatment for cancer approaches, LSCC may be an ideal disease for consideration of further treatment stratification and personalization. Here, we will discuss the important history of LSCC as a model system for organ preservation, unique and potentially targetable genetic signatures of LSCC, and methods for bringing stratified, personalized treatment strategies to the 21st century.",
keywords = "Genetics, Head and neck cancer, Laryngeal squamous cell carcinoma, Personalized medicine, Targeted therapy",
author = "Ludwig, {Megan L.} and Birkeland, {Andrew C.} and Rebecca Hoesli and Paul Swiecicki and Spector, {Matthew E.} and {Chad Brenner}, J.",
year = "2016",
month = "3",
day = "1",
doi = "10.28092/j.issn.2095-3941.2016.0010",
language = "English (US)",
volume = "13",
pages = "87--100",
journal = "Cancer Biology and Medicine",
issn = "2095-3941",
publisher = "Chinese Anticancer Association",
number = "1",

}

TY - JOUR

T1 - Changing the paradigm

T2 - the potential for targeted therapy in laryngeal squamous cell carcinoma

AU - Ludwig, Megan L.

AU - Birkeland, Andrew C.

AU - Hoesli, Rebecca

AU - Swiecicki, Paul

AU - Spector, Matthew E.

AU - Chad Brenner, J.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Laryngeal squamous cell carcinoma (LSCC) remains a highly morbid and fatal disease. Historically, it has been a model example for organ preservation and treatment stratification paradigms. Unfortunately, survival for LSCC has stagnated over the past few decades. As the era of next-generation sequencing and personalized treatment for cancer approaches, LSCC may be an ideal disease for consideration of further treatment stratification and personalization. Here, we will discuss the important history of LSCC as a model system for organ preservation, unique and potentially targetable genetic signatures of LSCC, and methods for bringing stratified, personalized treatment strategies to the 21st century.

AB - Laryngeal squamous cell carcinoma (LSCC) remains a highly morbid and fatal disease. Historically, it has been a model example for organ preservation and treatment stratification paradigms. Unfortunately, survival for LSCC has stagnated over the past few decades. As the era of next-generation sequencing and personalized treatment for cancer approaches, LSCC may be an ideal disease for consideration of further treatment stratification and personalization. Here, we will discuss the important history of LSCC as a model system for organ preservation, unique and potentially targetable genetic signatures of LSCC, and methods for bringing stratified, personalized treatment strategies to the 21st century.

KW - Genetics

KW - Head and neck cancer

KW - Laryngeal squamous cell carcinoma

KW - Personalized medicine

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=84969247915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969247915&partnerID=8YFLogxK

U2 - 10.28092/j.issn.2095-3941.2016.0010

DO - 10.28092/j.issn.2095-3941.2016.0010

M3 - Review article

AN - SCOPUS:84969247915

VL - 13

SP - 87

EP - 100

JO - Cancer Biology and Medicine

JF - Cancer Biology and Medicine

SN - 2095-3941

IS - 1

ER -